Summary
Analysis of genetic altera tion in circulating DNA can have clinical utility in predicting disease outcome. Loss of heterozygosity (LOH) of DNA microsatellites has been shown to occur commonly among all chromosomes in various cancers, such as melanoma, breast cancer, and lung cancer. In this protocol, we focused on the utility of LOH of microsatellite biomarkers for detection of analyzing circulating DNA. The protocol describes how PCR is performed on each patient’s paired DNA samples (normal lymphocyte DNA and serum DNA) using specific microsatellite biomarkers followed by post-PCR product analysis using capillary array electrophoresis (CAE). The utility of CAE is due to its digitalization and accuracy of the post-PCR product results.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
van der Riet P., Nawroz H., Hruban R. H., Corio R., Tokino K., Koch W., and Sidransky D. (1994) Frequent loss of chromosome 9p21–22 early in head and neck cancer progression. Cancer Res 54, 1156–1158.
Fujimoto A., Takeuchi H., Taback B., Hsueh E. C., Elashoff D., Morton D. L., and Hoon D. S. (2004) Allelic imbalance of 12q22–23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma. Cancer Res 64, 2245–2250.
Taback B., Giuliano A. E., Hansen N. M., and Hoon D. S. (2001) Microsatellite alterations detected in the serum of early stage breast cancer patients. Ann N Y Acad Sci 945, 22–30.
Umetani N., Fujimoto A., Takeuchi H., Shinozaki M., Bilchik A. J., and Hoon D. S. (2004) Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma. Oncogene 23, 8292–8300.
So C. K., Nie Y., Song Y., Yang G. Y., Chen S., Wei C., Wang L. D., Doggett N. A., and Yang C. S. (2004) Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma. Clin Cancer Res 10, 19–27.
Mihaila D., Jankowski M., Gutierrez J. A., Rosenblum M. L., Newsham I. F., Bogler O., and Rempel S. A. (2003) Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival. Clin Cancer Res 9, 4443–4451.
Califano J., Westra W. H., Meininger G., Corio R., Koch W. M., and Sidransky D. (2000) Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6, 347–352.
Nakayama T., Taback B., Turner R., Morton D. L., and Hoon D. S. (2001) Molecular clonality of in-transit melanoma metastasis. Am J Pathol 158, 1371–1378.
Fujiwara Y., Chi D. D., Wang H., Keleman P., Morton D. L., Turner R., and Hoon D. S. (1999) Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res 59, 1567–1571.
Fujimoto A., O'Day S. J., Taback B., Elashoff D., and Hoon D. S. (2004) Allelic imbalance on 12q22–23 in serum circulating DNA of melanoma patients predicts disease outcome. Cancer Res 64, 4085–4088.
Taback B., Fujiwara Y., Wang H. J., Foshag L. J., Morton D. L., and Hoon D. S. (2001) Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients. Cancer Res 61, 5723–5726.
Taback B., Saha S., and Hoon D. S. (2006) Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients. Ann N Y Acad Sci 1075, 197–203.
Chen X., Bonnefoi H., Diebold-Berger S., Lyautey J., Lederrey C., Faltin-Traub E., Stroun M., and Anker P. (1999) Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 5, 2297–2303.
Gonzalgo M. L., Eisenberger C. F., Lee S. M., Trock B. J., Marshall F. F., Hortopan S., Sidransky D., and Schoenberg M. P. (2002) Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res 8, 1878–1881.
Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., Pierotti M. A., and Tavecchio L. (2001) Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61, 4675–4678.
Utting M., Werner W., Dahse R., Schubert J., and Junker K. (2002) Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res 8, 35–40.
Eisenberger C. F., Knoefel W. T., Peiper M., Merkert P., Yekebas E. F., Scheunemann P., Steffani K., Stoecklein N. H., Hosch S. B., and Izbicki J. R. (2003) Squamous cell carcinoma of the esophagus can be detected by microsatellite analysis in tumor and serum. Clin Cancer Res 9, 4178–4183.
Nakayama T., Taback B., Nguyen D. H., Chi D. D., Morton D. L., Fujiwara Y., and Hoon D. S. (2000) Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients. Ann N Y Acad Sci 906, 87–98.
Taback B., O'Day S. J., Boasberg P. D., Shu S., Fournier P., Elashoff R., Wang H. J., and Hoon D. S. (2004) Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma. J Natl Cancer Inst 96, 152–156.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Nakamura, T., Sunami, E., Nguyen, T., Hoon, D.S. (2009). Analysis of Loss of Heterozygosity in Circulating DNA. In: Tainsky, M. (eds) Tumor Biomarker Discovery. Methods in Molecular Biology, vol 520. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-811-9_16
Download citation
DOI: https://doi.org/10.1007/978-1-60327-811-9_16
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-810-2
Online ISBN: 978-1-60327-811-9
eBook Packages: Springer Protocols